Neurocrine Biosciences, Inc. (NBIX) Q3 2026 earnings results
Neurocrine Biosciences, Inc. (NBIX) reported Q3 2026 results on Nov 2, 2026, 4:11:19 PM ET: adjusted EPS $3.29 vs. $2.75 expected (beat by 19.6%); revenue $1.12B. Outlook: INGREZZA net product sales guidance for full year 2026 was raised to a range of $2.9 billion to $2.925 billion.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $3.29 | $2.75 | Beat by 19.6% |
| Revenue | $1.12B | — | — |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 2, 2026, 4:11:19 PM ET. Nexqual published them 38 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 40.8% from $794.90M.
Stock reaction
The results came out after the market closed. NBIX closed at $164.85 on November 3, 2026, up 13.4% from its $145.35 close on November 2, 2026 before the results.
Questions and answers
Did Neurocrine Biosciences, Inc. beat earnings expectations?
Yes. Neurocrine Biosciences, Inc. reported adjusted EPS of $3.29 against an average analyst estimate of $2.75 (beat by 19.6%).
What were Neurocrine Biosciences, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $3.29 and revenue of $1.12B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 40.8% from $794.90M.
When did Neurocrine Biosciences, Inc. report Q3 2026 earnings?
Nov 2, 2026, 4:11:19 PM ET, in an SEC 8-K filing (Item 2.02).
How did NBIX stock react to the earnings?
The results came out after the market closed. NBIX closed at $164.85 on November 3, 2026, up 13.4% from its $145.35 close on November 2, 2026 before the results.
What did Neurocrine Biosciences, Inc. say about its outlook?
INGREZZA net product sales guidance for full year 2026 was raised to a range of $2.9 billion to $2.925 billion.
More on NBIX
NBIX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 2, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 4, 2026 at 10:48 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 4, 2026 at 10:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt